We assessed cardiovascular disease (CVD) incidence in 1474 survivors of Hodgkin
lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox …

Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …

Hodgkin lymphoma (HL) survivors treated with radiotherapy and/or chemotherapy are
known to have increased risks of heart failure (HF), but a radiation dose-response …

Purpose Cardiovascular diseases are increasingly recognized as late effects of Hodgkin
lymphoma (HL) treatment. The purpose of this study was to identify the risk factors for …

The risk of cardiac hospitalization (CH) in Hodgkin lymphoma (HL) patients with preexisting
heart disease was evaluated. Patients with HL were identified from a population-based …

This study assessed the cumulative incidence of clinically significant cardiac disease in
1279 Hodgkin lymphoma patients treated with mediastinal irradiation and quantified the …

Background: Hodgkin lymphoma (HL) survivors are at increased risk for developing valvular
heart disease (VHD). We evaluated the determinants of the risk and the radiation dose …

Patients diagnosed with Hodgkin lymphoma have a high cure rate. However, long‐term
survivors of the disease are at significantly increased risk for a number of late effects, with …

Background The magnitude of cardiovascular morbidity in paediatric, adolescent, and young
adult survivors of Hodgkin's lymphoma is not known. Using medically ascertained data, we …

Purpose Mediastinal radiation therapy (RT) for Hodgkin lymphoma (HL) is associated with
late cardiotoxicity, but there are limited data to indicate which dosimetric parameters are …